Literature DB >> 23331790

Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee.

Kenneth W Gow1, Douglas C Barnhart, Thomas E Hamilton, Jessica J Kandel, Mike K S Chen, Fernando A Ferrer, Mitchell R Price, Elizabeth A Mullen, James I Geller, Eric J Gratias, Nancy Rosen, Geetika Khanna, Arlene Naranjo, Michael L Ritchey, Paul E Grundy, Jeffrey S Dome, Peter F Ehrlich.   

Abstract

PURPOSE: Initial Children's Oncology Group (COG) management for Wilms' tumor (WT) consists of primary nephroureterectomy with lymph node sampling. While this provides accurate staging to define further treatment, it may result in intraoperative spill (IOS), which is associated with higher recurrence rates and therefore requires more intensive therapy. The purpose of this study is to determine current rates and identify factors which may predispose a patient to IOS.
METHODS: The study population was drawn from the AREN03B2 renal tumor banking and classification study of the Children's Oncology Group. All children with a first time occurrence of a renal mass were eligible for the study. At the time of enrollment and prior to risk stratification, the institution is required to submit operative notes, pathology specimens, a chest computed tomography scan (CT), and a contrast-enhanced CT or magnetic resonance imaging (MRI) of the abdomen and pelvis for central imaging review. These data are then used to determine an initial risk classification and therapeutic protocol eligibility. Patients who had a unilateral nephroureterectomy for favorable histology WT underwent further review to assure data accuracy and to clarify details regarding the spill. Analyses were performed using chi square and logistic regression. Odd ratios (OR) are shown with 95% confidence intervals.
RESULTS: There were 1,131 primary nephrectomies for unilateral WT with an IOS rate of 9.7% with an additional 1.8% having possible tumor spill during renal vein or IVC tumor thrombectomy. IOS correlated with diameter (>12 cm, p<0.0001) and laterality (right, p=0.0414). Simple logistic regression indicated that IOS increased 2.7% [p=0.0240, OR 1.027 (1.004, 1.052)] with each 1 cm increase in diameter (3 - 21 cm) and 4.7% [p=0.0147 OR 1.047 (1.009, 1.086)] with each 100 g increase in weight (80 - 1800 g). Multiple logistic regression indicated that laterality [right p=0.048, OR 1.46 (1.004, 2.110)] and weight (p=0.03, OR 1.039 (1.003, 1.075) were predictive of IOS when diameter was included as a continuous variable. Diameter as a binary variable was highly prognostic of IOS (p=0.0002), while laterality and weight were not significant.
CONCLUSIONS: Intraoperative tumor spill occurs in about one out of every ten cases of primary nephroureterectomies for WT. Right-sided and larger tumors are at higher risk of IOS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23331790      PMCID: PMC4556229          DOI: 10.1016/j.jpedsurg.2012.10.015

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  18 in total

1.  Surgical complications after primary nephrectomy for Wilms' tumor: report from the National Wilms' Tumor Study Group.

Authors:  M L Ritchey; R C Shamberger; G Haase; J Horwitz; T Bergemann; N E Breslow
Journal:  J Am Coll Surg       Date:  2001-01       Impact factor: 6.113

2.  Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5.

Authors:  Peter F Ehrlich; Michael L Ritchey; Tomas E Hamilton; Gerald M Haase; San Ou; Norman Breslow; Paul Grundy; Daniel Green; Patricia Norkool; Jennifer Becker; Robert C Shamberger
Journal:  J Pediatr Surg       Date:  2005-01       Impact factor: 2.545

3.  The surgical treatment of Wilms' tumor: results of the National Wilms' Tumor Study.

Authors:  L L Leape; N E Breslow; H C Bishop
Journal:  Ann Surg       Date:  1978-04       Impact factor: 12.969

4.  Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9". International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee.

Authors:  J Godzinski; M F Tournade; J deKraker; J Lemerle; P A Voute; A Weirich; R Ludwig; M Rapala; G Skotnicka; F Gauthier; C G Moorman-Voestermans; D Buerger; A VanVeen; K Sawicz-Birkowska
Journal:  Eur J Pediatr Surg       Date:  1998-04       Impact factor: 2.191

5.  Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis--results of the second National Wilms' Tumor Study.

Authors:  N Breslow; G Churchill; J B Beckwith; D J Fernbach; H B Otherson; M Tefft; G J D'Angio
Journal:  J Clin Oncol       Date:  1985-04       Impact factor: 44.544

6.  [Resection of nephroblastoma: problems and complications--evaluation of the Nephroblastoma Study SIOP 9/GPOH].

Authors:  H Roth; A Weirich; R Ludwig; R Daum; H Zimmermann
Journal:  Langenbecks Arch Chir Suppl Kongressbd       Date:  1996

7.  Intravascular extension of Wilms tumor.

Authors:  R C Shamberger; M L Ritchey; G M Haase; T L Bergemann; T Loechelt-Yoshioka; N E Breslow; D M Green
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

8.  Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.

Authors:  P Grundy; N Breslow; D M Green; K Sharples; A Evans; G J D'Angio
Journal:  J Clin Oncol       Date:  1989-05       Impact factor: 44.544

9.  Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4.

Authors:  R C Shamberger; K A Guthrie; M L Ritchey; G M Haase; J Takashima; J B Beckwith; G J D'Angio; D M Green; N E Breslow
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

10.  Wilms' tumor 1991. Clinical evaluation and treatment.

Authors:  P R Exelby
Journal:  Urol Clin North Am       Date:  1991-08       Impact factor: 2.241

View more
  13 in total

1.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

2.  Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: implications for central venous catheter placement.

Authors:  Fernando A Ferrer; Katherine W Herbst; Conrad V Fernandez; Geetika Khanna; Jeffrey S Dome; Arlene Naranjo; Elizabeth A Mullen; James I Geller; Eric J Gratias; Robert Shamberger; Michael Ritchey; Peter F Ehrlich
Journal:  J Pediatr Urol       Date:  2014-03-15       Impact factor: 1.830

Review 3.  Management of Wilms Tumor: ICMR Consensus Document.

Authors:  Maya Prasad; Tushar Vora; Sandeep Agarwala; Siddharth Laskar; Brijesh Arora; Deepak Bansal; Gauri Kapoor; Girish Chinnaswamy; Venkatraman Radhakrishnan; Tanvir Kaur; G K Rath; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2017-04-03       Impact factor: 1.967

4.  Factors responsible for stage III disease in patients with Wilms tumor enrolled in the JWiTS-2 study.

Authors:  Takaharu Oue; Koji Fukumoto; Ryota Souzaki; Tetsuya Takimoto; Tsugumichi Koshinaga
Journal:  Pediatr Surg Int       Date:  2019-08-08       Impact factor: 1.827

5.  Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group.

Authors:  Peter Ehrlich; Yuen Y Chi; Murali M Chintagumpala; Fred A Hoffer; Elizabeth J Perlman; John A Kalapurakal; Ann Warwick; Robert C Shamberger; Geetika Khanna; Tom E Hamilton; Ken W Gow; Arnold C Paulino; Eric J Gratias; Elizabeth A Mullen; James I Geller; Paul E Grundy; Conrad V Fernandez; Michael L Ritchey; James S Dome
Journal:  Ann Surg       Date:  2017-09       Impact factor: 12.969

6.  Predictive factor for intraoperative tumor rupture of Wilms tumor.

Authors:  Hiroaki Fukuzawa; Yuko Shiima; Yasuhiko Mishima; Sachi Sekine; Shizu Miura; Kiyoaki Yabe; Satoshi Yamaki; Keiichi Morita; Yuichi Okata; Chieko Hisamatsu; Makoto Nakao; Akiko Yokoi; Kosaku Maeda; Yoshiyuki Kosaka
Journal:  Pediatr Surg Int       Date:  2016-11-01       Impact factor: 1.827

7.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

8.  Advances in the treatment of pediatric solid tumors: A 50-year perspective.

Authors:  Michael P LaQuaglia; Justin T Gerstle
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

9.  Image-based surgical risk factors for Wilms tumor.

Authors:  Takaharu Oue; Akihiro Yoneda; Noriaki Usui; Takashi Sasaki; Masahiro Zenitani; Natsumi Tanaka; Shuichiro Uehara; Soji Ibuka; Yuichi Takama; Hiroomi Okuyama
Journal:  Pediatr Surg Int       Date:  2017-11-08       Impact factor: 1.827

10.  Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group.

Authors:  Peter F Ehrlich; Thomas E Hamilton; Kenneth Gow; Douglas Barnhart; Fernando Ferrer; Jessica Kandel; Richard Glick; Roshni Dasgupta; Arlene Naranjo; Ying He; Elizabeth J Perlman; John A Kalapurakal; Geetika Khanna; Jeffrey S Dome; James Geller; Elizabeth Mullen
Journal:  Pediatr Blood Cancer       Date:  2016-05-27       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.